In… public comments on behalf of the Sacklers, White told me why the family believed the litigation against them and their company is legally dubious, factually misleading and politically motivated. The claims are gargantuan: An expert plaintiffs’ witness in the nationwide MDL in Cleveland recently estimated that it will cost nearly half a trillion dollars…
The London-based biotech is advancing the drug, [one of the many] active ingredient[s] in magic mushrooms … Compass has partnered with academic centers, primarily in the U.S. …is advancing the clinical program while also working on earlier-stage projects. The biotech… focuse[s] on psilocybin therapy in the belief it could leverage existing knowledge of the drug…
The increasing success of FDA-approved cannabinoid therapeutics helps drive the interest in psychedelics. ClinicalTrials.gov lists more than 400 trials involving cannabinoids. As its effectiveness is shown, the compound gains traction within the pharmaceutical industry as a possible active ingredient in a variety of therapeutics. “We were fortunate to watch the cannabis industry grow into a…
The success of the campaign “just shocked people,” [Kevin Matthews of IP-301 which allows individuals to cultivate psilocybin-containing mushrooms at home for personal use] said… through a combination of education, outreach and innovation – as well as the open-mindedness of the local electorate – the campaign prevailed. More remarkable than the policy change in Denver,…
…mental health clinic that provides IV ketamine infusions to treat mood disorders and chronic pain, is keeping its… facility open… Chief Operating Officer Sam Mandel says, “Our aim is to help patients and their families make well-informed decisions about their mental health by providing the latest data in a compassionate manner.” Original Article (Digital Journal):Ketamine…
The legal pressure on the prominent family behind the company that makes OxyContin, the prescription painkiller that helped fuel the nation’s opioid epidemic, is likely to get more intense … Having Sackler family members named as defendants in Massachusetts “indicates that the government attorneys believe they have the ‘smoking guns’ necessary to broaden the potential liability…
New York’s attorney general… told a U.S.bankruptcy [on April 29th, 2020] court that the Sackler family, owners of Purdue Pharma LP, have slow-rolled and resisted discovery requests into their finanancial information. AG Letitia James said that the Sackler’s have produced few primary documents in the six months to make voluntary disclosures about their finances. The…
…scientific team [claims it] sees tremendous opportunities for both composition of matter as well as process innovations in the psychedelic arena, and we will simultaneously pursue these opportunities to expand Mindset’s IP library. Mindset CEO James Lanthier commented: “Synthesizing patentable, next-generation compounds is a critical step in our pre-clinical work as we make progress towards…
Dr. Michael Hoffer [otolaryngologists; also known ear, nose & throat doctors), has secured a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. The psilocybin is to be provided by the same organization that has supplied both Johns Hopkins University and Yale University throughout their…
As Washington was one of the first states to legalize recreational marijuana, there was this necessity to keep it “clean” and legitimate. “Washington state purposely excluded folks with criminal records, which disproportionately impacted folks in the medical [marijuana] community, because a lot of them had felony convictions for transporting and selling medicinal products,” [Michele] Cadigan said.…
